Continuous glucose monitors were built for type 1 diabetes. Evidence and regulators are now pulling them into type 2 care — a far larger market and mission.
Notice: Paid authorship is offered here. Daily review of every submission cannot be ensured. The owner does not endorse or promote illegal services including casinos, gambling, betting, or CBD.
